Package 50090-3389-3

{"route": ["ORAL"], "spl_id": "c3bc6965-397a-4657-ae62-c05a29568265", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199889"], "spl_set_id": ["f16b14a2-297f-4adb-8d7a-5f43785faef7"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (50090-3389-0)", "package_ndc": "50090-3389-0", "marketing_start_date": "20180307"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-3389-1)", "package_ndc": "50090-3389-1", "marketing_start_date": "20181008"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-3389-2)", "package_ndc": "50090-3389-2", "marketing_start_date": "20180307"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (50090-3389-3)", "package_ndc": "50090-3389-3", "marketing_start_date": "20231106"}], "brand_name": "Topiramate", "product_id": "50090-3389_c3bc6965-397a-4657-ae62-c05a29568265", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "50090-3389", "generic_name": "Topiramate", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20140612", "listing_expiration_date": "20261231"}